Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Completeness of solution 641
Mix 1.0 g with 10 mL of carbon dioxide-free water: after 1 minute, the solution is clear and free from undissolved solid.
Identification
B:
Ignite about 200 mg: the residue effervesces with acid and responds to the tests for
Sodium 191.
Loss on drying 731
Dry about 1 g, accurately weighed, at 105
for 4 hours: it loses not more than 2.0% of its weight.
Heavy metals, Method II 231:
0.003%.
Organic volatile impurities, Method I 467:
meets the requirements.
Assay
Dissolve about 500 mg of Amobarbital Sodium, accurately weighed, in about 15 mL of water in a separator. To the solution add 2 mL of hydrochloric acid, shake, and completely extract the liberated amobarbital with 25-mL portions of chloroform. Test for completeness of extraction by extracting with an additional 10-mL portion of chloroform and evaporating the solvent: not more than 0.5 mg of residue remains. Filter the combined extract through a glass filter funnel into a tared beaker, and wash the separator and the filter with several small portions of chloroform. Evaporate the combined filtrate and washings on a steam bath with the aid of a current of air, dry the residue at 105
for 30 minutes, cool, and weigh. The weight of the residue, multiplied by 1.097, represents the weight of C
11H
17N
2NaO
3.
Auxiliary Information
Staff Liaison :
Ravi Ravichandran, Ph.D., Senior Scientist
Expert Committee : (MDPP05) Monograph Development-Psychiatrics and Psychoactives
USP29NF24 Page 153
Pharmacopeial Forum : Volume No. 29(6) Page 1845
Phone Number : 1-301-816-8330